• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜经鼻蝶窦和显微镜经蝶窦手术治疗无功能垂体腺瘤的疗效:系统评价和荟萃分析。

Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis.

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Neurosurgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

出版信息

J Cell Mol Med. 2018 Mar;22(3):2023-2027. doi: 10.1111/jcmm.13445. Epub 2018 Jan 4.

DOI:10.1111/jcmm.13445
PMID:29314715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5824383/
Abstract

Both microscopic and endoscopic transsphenoidal surgery are effective approaches for nonfunctioning pituitary adenomas. The issue on the comparison of their efficacy and safety remains inconsistent. A thorough search of the literatures (PubMed, EMBASE, MEDLINE) were performed up to March 2017. Studies reporting outcomes of microscopic or endoscopic transsphenoidal surgery on nonfunctioning pituitary adenomas were included. A meta-analysis was performed focusing on the early stage and long term outcomes. The final search yielded 19 eligible studies enrolling 3847 patients, 389 of them underwent microscopic approach and 3458 of them with endoscopic approach. As to the early stage outcomes, the rate of gross tumor resection was significantly higher in the endoscopic group than that in microscopic group (73% versus 60%, P < 0.001). Meanwhile, endoscopic approach showed priority over microscopy on postoperative hypopituitarism (63% versus 65%, P < 0.001) and CSF leakage (3% versus 7%, P < 0.001). For the long term outcomes, the rate of visual improvement was significant higher in the endoscopic group than that in microscopic group (77% versus 50%, P < 0.001). However, there was no significant difference between the groups regarding the rate of permanent diabetic insipidus and meningitis. The endoscopic approach may be associated with higher rate of gross tumor movement and lower risk of postoperatively complications for treating nonfunctioning pituitary adenoma, when compared with microscopic approach. However, the confidence was shorted due to limited high quality evidence (largely randomized and controlled studies).

摘要

经蝶窦显微手术和内镜手术治疗无功能垂体腺瘤均有效,但两者的疗效和安全性比较仍存在争议。我们对PubMed、EMBASE 和 MEDLINE 等数据库进行了全面检索,检索时限截至 2017 年 3 月。纳入比较经蝶窦显微手术和内镜手术治疗无功能垂体腺瘤的研究,采用 Meta 分析方法对近期和远期疗效进行分析。最终共纳入 19 项研究,包括 3847 例患者,其中 389 例行经蝶窦显微手术,3458 例行经蝶窦内镜手术。近期疗效方面,内镜组肿瘤全切率显著高于显微组(73%比 60%,P<0.001),但术后垂体功能低下(63%比 65%,P<0.001)和脑脊液漏(3%比 7%,P<0.001)发生率低于显微组。远期疗效方面,内镜组视力改善率显著高于显微组(77%比 50%,P<0.001)。但两组永久性尿崩症和脑膜炎发生率差异无统计学意义。与经蝶窦显微手术相比,内镜手术治疗无功能垂体腺瘤可能具有肿瘤全切率高、术后并发症风险低的优势,但由于证据质量不高(主要为随机对照研究),其结论可信度有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614f/5824383/fc29d445aa46/JCMM-22-2023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614f/5824383/fc29d445aa46/JCMM-22-2023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/614f/5824383/fc29d445aa46/JCMM-22-2023-g001.jpg

相似文献

1
Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis.内镜经鼻蝶窦和显微镜经蝶窦手术治疗无功能垂体腺瘤的疗效:系统评价和荟萃分析。
J Cell Mol Med. 2018 Mar;22(3):2023-2027. doi: 10.1111/jcmm.13445. Epub 2018 Jan 4.
2
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.经验较少的外科医生采用完全内镜技术与经验非常丰富的外科医生采用显微镜下经蝶窦技术治疗垂体腺瘤的疗效比较。
J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16.
3
Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.单名外科医生学习曲线后331例无功能垂体腺瘤的内镜经蝶窦手术结果
World Neurosurg. 2018 Jan;109:e409-e416. doi: 10.1016/j.wneu.2017.09.194. Epub 2017 Oct 7.
4
Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis.内镜与显微镜下经蝶窦手术治疗垂体腺瘤的系统评价与Meta分析
World Neurosurg. 2017 May;101:236-246. doi: 10.1016/j.wneu.2017.01.022. Epub 2017 Jan 16.
5
Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp Grades 0-2 nonfunctioning pituitary macroadenomas at a single institution.对单一机构中Knosp 0-2级无功能垂体大腺瘤的显微手术与内镜经蝶窦手术同期系列病例进行回顾性分析。
J Neurosurg. 2014 Sep;121(3):511-7. doi: 10.3171/2014.6.JNS131321. Epub 2014 Jul 4.
6
Pure Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Adenomas in the Elderly: Surgical Outcomes and Complications in 158 Patients.老年无功能垂体腺瘤的单纯内镜鼻内经蝶窦入路:158例患者的手术结果及并发症
World Neurosurg. 2015 Dec;84(6):1572-8. doi: 10.1016/j.wneu.2015.08.035. Epub 2015 Sep 1.
7
Learning curve for the transsphenoidal endoscopic endonasal approach to pituitary tumors.经蝶窦内镜鼻内入路治疗垂体瘤的学习曲线
Br J Neurosurg. 2016 Dec;30(6):637-642. doi: 10.1080/02688697.2016.1199786. Epub 2016 Jun 22.
8
Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.经鼻内镜蝶窦入路切除大型和巨大型垂体腺瘤:机构经验和影响切除程度的预测因素。
J Neurosurg. 2014 Jul;121(1):75-83. doi: 10.3171/2014.3.JNS131679. Epub 2014 May 2.
9
Postoperative Complications of Endoscopic Versus Microscopic Transsphenoidal Pituitary Surgery: A Meta-Analysis.内镜与显微镜下经蝶窦垂体手术的术后并发症:一项Meta分析
J Coll Physicians Surg Pak. 2018 Jul;28(7):554-559. doi: 10.29271/jcpsp.2018.07.554.
10
Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas.经唇下或内镜经鼻蝶窦入路显微手术治疗无功能垂体腺瘤的鼻-鼻窦结局的前瞻性比较。
J Neurosurg. 2016 Aug;125(2):323-33. doi: 10.3171/2015.6.JNS142695. Epub 2015 Dec 11.

引用本文的文献

1
Assessing surgical outcomes in pituitary adenoma: A comparison of microscopic and endoscopic techniques.垂体腺瘤手术结果评估:显微镜与内镜技术的比较
Surg Neurol Int. 2025 Jun 13;16:234. doi: 10.25259/SNI_1092_2024. eCollection 2025.
2
Safety and efficacy of endoscopic vs. microscopic approaches in pituitary adenoma surgery: A systematic review and meta-analysis.垂体腺瘤手术中内镜与显微镜入路的安全性和有效性:一项系统评价和荟萃分析。
Neurosurg Rev. 2025 Jun 1;48(1):471. doi: 10.1007/s10143-025-03600-3.
3
The Impact of Surgical Telementoring on Reducing the Complication Rate in Endoscopic Endonasal Surgery of the Skull Base.

本文引用的文献

1
Endoscopic Skull Base Reconstruction: An Evolution of Materials and Methods.内镜颅底重建:材料与方法的演变
Otolaryngol Clin North Am. 2017 Jun;50(3):643-653. doi: 10.1016/j.otc.2017.01.015. Epub 2017 Mar 31.
2
Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis.内镜与显微镜下经蝶窦手术治疗垂体腺瘤的系统评价与Meta分析
World Neurosurg. 2017 May;101:236-246. doi: 10.1016/j.wneu.2017.01.022. Epub 2017 Jan 16.
3
Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone-Secreting Pituitary Adenomas-Systematic Review and Meta-Analysis.
手术远程指导对降低颅底鼻内镜手术并发症发生率的影响
Diagnostics (Basel). 2024 Aug 27;14(17):1874. doi: 10.3390/diagnostics14171874.
4
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis.靶向 HTR2B 抑制无功能垂体腺瘤生长,并通过抑制 Gαq/PLC/PKCγ/STAT3 轴增强卡麦角林的治疗作用。
Neuro Oncol. 2024 Nov 4;26(11):2010-2026. doi: 10.1093/neuonc/noae130.
5
Insights into Visual Outcomes and Determinants in Pituitary Adenoma Surgery: A 5-Year Retrospective Cohort Study.垂体腺瘤手术的视觉结果及决定因素分析:一项5年回顾性队列研究
Clin Ophthalmol. 2024 Jun 21;18:1779-1788. doi: 10.2147/OPTH.S463303. eCollection 2024.
6
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing's disease: safety, feasibility, and success.内镜经鼻蝶窦重复手术治疗残余或复发性库欣病:安全性、可行性和疗效。
Pituitary. 2024 Jun;27(3):259-268. doi: 10.1007/s11102-024-01396-x. Epub 2024 May 15.
7
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.非功能性垂体神经内分泌肿瘤的诊断和治疗的最新证据更新。
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
8
A randomized prospective comparative study on sinonasal morbidity and quality of life of transsphenoidal endoscopic surgery for pituitary adenomas: endonasal versus trans-septal approach.经蝶窦内镜手术治疗垂体腺瘤的鼻-鼻窦并发症和生活质量的随机前瞻性对比研究:经鼻入路与经鼻中隔入路。
Eur Arch Otorhinolaryngol. 2024 Jan;281(1):257-266. doi: 10.1007/s00405-023-08216-1. Epub 2023 Sep 6.
9
Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis.非功能性垂体腺瘤术后结局:一项基于患者水平的荟萃分析。
Pituitary. 2023 Aug;26(4):461-473. doi: 10.1007/s11102-023-01335-2. Epub 2023 Jun 30.
10
Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.囊性与非囊性无功能性促肾上腺皮质腺瘤:经蝶显微手术治疗 62 例回顾性单中心研究——临床与组织学分析
Sci Rep. 2023 Feb 11;13(1):2468. doi: 10.1038/s41598-023-29628-3.
经鼻内镜与显微经蝶入路治疗生长激素分泌型垂体腺瘤的系统评价和Meta分析
World Neurosurg. 2017 Jan;97:398-406. doi: 10.1016/j.wneu.2016.10.029. Epub 2016 Oct 15.
4
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Patients With Nonfunctioning Pituitary Adenomas: Executive Summary.神经外科医师协会关于无功能垂体腺瘤患者管理的系统评价与循证指南:执行摘要
Neurosurgery. 2016 Oct;79(4):521-3. doi: 10.1227/NEU.0000000000001386.
5
Complications Related to the Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Macroadenomas in 300 Consecutive Patients.300例连续患者经鼻内镜下经蝶窦入路切除无功能垂体大腺瘤的相关并发症
World Neurosurg. 2016 May;89:442-53. doi: 10.1016/j.wneu.2016.02.059. Epub 2016 Feb 20.
6
Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas.经唇下或内镜经鼻蝶窦入路显微手术治疗无功能垂体腺瘤的鼻-鼻窦结局的前瞻性比较。
J Neurosurg. 2016 Aug;125(2):323-33. doi: 10.3171/2015.6.JNS142695. Epub 2015 Dec 11.
7
Comparison of outcomes between a less experienced surgeon using a fully endoscopic technique and a very experienced surgeon using a microscopic transsphenoidal technique for pituitary adenoma.经验较少的外科医生采用完全内镜技术与经验非常丰富的外科医生采用显微镜下经蝶窦技术治疗垂体腺瘤的疗效比较。
J Neurosurg. 2016 Mar;124(3):596-604. doi: 10.3171/2015.4.JNS15102. Epub 2015 Oct 16.
8
Nonfunctioning Pituitary Adenomas Are Really Clinically Nonfunctioning? Clinical and Endocrinological Symptoms and Outcomes with Endoscopic Endonasal Treatment.无功能垂体腺瘤真的在临床上无功能吗?经鼻内镜治疗后的临床及内分泌症状与结局
World Neurosurg. 2016 Jan;85:185-92. doi: 10.1016/j.wneu.2015.08.073. Epub 2015 Sep 4.
9
Pure Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Adenomas in the Elderly: Surgical Outcomes and Complications in 158 Patients.老年无功能垂体腺瘤的单纯内镜鼻内经蝶窦入路:158例患者的手术结果及并发症
World Neurosurg. 2015 Dec;84(6):1572-8. doi: 10.1016/j.wneu.2015.08.035. Epub 2015 Sep 1.
10
Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.女性和青年非功能性垂体腺瘤患者的超额死亡率:一项瑞典全国性研究。
J Clin Endocrinol Metab. 2015 Jul;100(7):2651-8. doi: 10.1210/jc.2015-1475. Epub 2015 May 6.